drugset / Trial / NCT04771767

Combined Ketamine and eCBT Intervention for PTSD

NCT04771767 ↗

Phase 2 Unknown 16 enrolled Queen's University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

An open label RCT assessing the efficacy of a combined treatment approach for PTSD, using Ketamine infusions and online Cognitive Behavioural Therapy.

Timeline

Start
2021-08-01
Primary completion
2024-03-31
Completion
2024-03-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule — Intravenous